This generic and specialty drugmaker's experimental gut inflammation treatment showed durable results in a mid-stage clinical trial, offering fresh ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE